Syra Health (Syra Health) EBIT : $-3.55 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Syra Health EBIT?

Syra Health's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-1.44 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.55 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Syra Health's annualized ROC % for the quarter that ended in Mar. 2024 was -845.71%. Syra Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -1,188.88%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Syra Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -62.43%.

Syra Health EBIT Historical Data

The historical data trend for Syra Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syra Health EBIT Chart

Syra Health Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBIT

-2.09

-2.89

Syra Health Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial					-0.77	-0.78	-0.34	-0.99	-1.44

Competitive Comparison of Syra Health's EBIT

For the Medical Care Facilities subindustry, Syra Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syra Health's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Syra Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Syra Health's EV-to-EBIT falls into.

Syra Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.55 Mil.

Syra Health (NAS:SYRA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Syra Health's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-5.624 * ( 1 - 0% )	/	( (0.981	+	0.349)	/ 2 )
=	-5.624	/	0.665
=	-845.71 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4.923	-	0.662	-	( 3.28	-	max(0, 0.91	-	4.781	+	3.28	))
=	0.981

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4.552	-	0.965	-	( 3.238	-	max(0, 1.102	-	4.448	+	3.238	))
=	0.349

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Syra Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-5.772	/	( ( (0.142 + max(0.716, 0))	+	(0.104 + max(0.009, 0)) )	/	2 )
=	-5.772	/	( ( 0.858	+	0.113 )	/	2 )
=	-5.772	/	0.4855
=	-1,188.88 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.061	+	0	+	0.317)	-	(0.662	+	0	+	0)
=	0.716

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.746	+	0	+	0.234)	-	(0.965	+	0.006	+	0)
=	0.009

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Syra Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-3.553	/	5.691
	=	-62.43 %

Syra Health EBIT Related Terms

Thank you for viewing the detailed overview of Syra Health's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Syra Health (Syra Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Syra Health Corp (NAS:SYRA) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032

Website

https://www.syrahealth.com

Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The Company has two main forms of revenue - healthcare staffing revenue and medical communication revenue. The majority of revenue is derived from healthcare staffing.

Executives

Sandeep Allam	director, officer: President and Chair	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Feroz Syed	10 percent owner	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Deepika Vuppalanchi	director, officer: Chief Executive Officer	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Vijayapal Reddy	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Avutu Reddy	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Ketan Paranjape	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Andrew Dahlem	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Sherron Rogers	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Joe D Thomas	10 percent owner	2046 EAST MURRAY-HOLIDAY ROAD, SALT LAKE CITY UT 84117
Sls Group Llc	10 percent owner	6582 S BIG COTTONWOOD CANYON RD. #200, SALT LAKE CITY UT 84121
Priya Prasad	officer: CFO and COO	1119 KEYSTONE WAY N., #201, CARMEL IN 46032